Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...

The American College of Cardiology (ACC) has issued its first Concise Clinical Guidance (CCG) to create more streamlined and efficient processes to implement best practices in patient care. This CCG ...

Cardiogenic shock, often caused by heart failure, is marked by dangerously low blood pressure that compromises blood flow to ...

Cardiogenic shock defined as systolic blood pressure < 90 and signs of hypoperfusion such as oliguria, cyanosis, and sweating (mortality 67%) The original data from 1967 showed the above mortality ...

Cardiogenic shock remains a challenging clinical syndrome characterized by critically impaired cardiac output, systemic hypoperfusion, and high mortality ...

The US data also point to lower costs and shorter stays at these expert centers, an argument for regionalized care akin to ...

Early cardiogenic shock, categorized as SCAI Stage B, is marked by dangerously low blood pressure, which compromises blood flow to vital organs. Without timely intervention, the condition often ...

In this “data-scarce zone,” the paper offers a road map for the first 24 hours and tips for transfer, teams, and more.

The following is a summary of "In-hospital outcomes of cardiogenic shock patients: A propensity score-matched nationwide ...

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

The following is a summary of “ICU mortality of post-myocardial infarction ventricular septal defect complicated by cardiogenic shock: a retrospective multicentric cohort,” published in the March 2025 ...

The company’s lead asset, Istaroxime, is a first-in-class, dual-acting agent being developed to improve blood pressure and cardiac function in patients with cardiogenic shock. A second ...